Clinical Benefit of Pembrolizumab in Patients with Previously Treated Advanced Clear Cell Gynaecological Cancers By Ogkologos - March 4, 2025 647 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the PEACOCC study Source RELATED ARTICLESMORE FROM AUTHOR EMA Recommends Extension of Therapeutic Indications for Retifanlimab Adding Palbociclib to Maintenance Anti-HER2 and Endocrine Therapies Improves PFS Over Standard Therapy in Patients with HR-positive, HER2-positive MBC FDA Grants Traditional Approval to Pirtobrutinib for Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma MOST POPULAR News digest – cancer blood test, gum disease and junk food... July 25, 2020 Vax-On Points to Maintenance of Active Anticancer Treatment Throughout the Whole... September 24, 2021 Palliative and Supportive Care for Children With Cancer: An Expert Perspective October 5, 2023 Colorectal Cancer Screening: The Silver Lining September 1, 2020 Load more HOT NEWS New Research in Treating Metastatic Breast Cancer, Preventing Breast Cancer, and... NCI-MATCH Update: More Labs, New Arms, and Initial Findings Removing senescent immune cells could be the key to preventing some... Biomedical Engineering Student Invents Device for At-Home Breast Cancer Screening
